The effects of oral taurine administration on behavior and hippocampal signal transduction in rats

Amino Acids

Volumn 43, Issue 5, 2012, Pages 2037-2046

  Iio, Wataru ^a,b   Matsukawa, Noriko ^c   Tsukahara, Takamitsu ^c   Toyoda, Atsushi ^a,b  

^a IBARAKI UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c Ujitawara cho   (Japan)

Author keywords

Antidepressant; Behavior; CaMKII; Rat; Taurine

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TAURINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; FOOD INTAKE; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSION; DIET; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; SWIMMING; TAURINE;

RATTUS;

EID: 84868099210     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1282-2     Document Type: Article

References (56)

1. Albrecht J, Schousboe A (2005) Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem Res 30:1615-1621 (Pubitemid 41813726)
2. Altamura C, Maes M, Dai J, Meltzer HY (1995) Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur Neuropsychopharmacol 5(Suppl):71-75 (Pubitemid 26017262)
3. Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, Drago F, Racagni G, Popoli M (2007) Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychophar-macology 32:2511-2519 (Pubitemid 350126831)
4. Berton O, Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151 (Pubitemid 43151600)
5. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M (2005) Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25:3270-3279 (Pubitemid 40471335)
6. Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sci 75:1503-1511 (Pubitemid 38887277)
7. del Olmo N, Bustamante J, del Río RM, Solís JM (2000a) Taurine activates GABA(A) but not GABA(B) receptors in rat hippo-campal CA1 area. Brain Res 864:298-307 (Pubitemid 30235111)
8. del Olmo N, Galarreta M, Bustamante J, Martín del Rio R, Solís JM (2000b) Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 39:40-54
9. del Olmo N, Handler A, Alvarez L, Bustamante J, Martín del Río R, Solís JM (2003) Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 44:26-39 (Pubitemid 36135839)
10. Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuénod M, Holsboer F (1995) Gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem 65:2652-2662 (Pubitemid 3002922)
11. Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377-32379 (Pubitemid 28557606)
12. Fatemi SH, Reutiman TJ, Folsom TD, Huang H, Oishi K, Mori S, Smee DF, Pearce DA, Winter C, Sohr R, Juckel G (2008) Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neuro-developmental disorders. Schizophr Res 99:56-70
13. Fukuo Y, Kishi T, Kushima I, Yoshimura R, Okochi T, Kitajima T, Matsunaga S, Kawashima K, Umene-Nakano W, Naitoh H, Inada T, Nakamura J, Ozaki N, Iwata N (2011) Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. J Affect Disord 133:150-157
14. Galarreta M, Bustamante J, Martín del Río R, Solís JM (1996) Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J Neurosci 16:92-102 (Pubitemid 26010702)
15. Grimes CA, Jope RS (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78:1219-1232 (Pubitemid 32899754)
16. Han F, Nakano T, Yamamoto Y, Shioda N, Lu YM, Fukunaga K (2009) Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbec-tomized mice. Brain Res 1265:205-214
17. Hernández-Benítez R, Pasantes-Morales H, Saldaña IT, Ramos-Mandujano G (2010) Taurine stimulates proliferation of mice embryonic cultured neural progenitor cells. J Neurosci Res 88:1673-1681
18. Hussy N, Deleuze C, Desarménien MG, Moos FC (2000) Osmotic regulation of neuronal activity: a new role for taurine and glial cells in a hypothalamic neuroendocrine structure. Prog Neuro-biol 62:113-134 (Pubitemid 30316442)
19. Iio W, Matsukawa N, Tsukahara T, Kohari D, Toyoda A (2011) Effects of chronic social defeat stress on MAP kinase cascade. Neurosci Lett 504:281-284
20. Inan SY, Yalcin I, Aksu F (2004) Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation. Pharmacol Biochem Behav 77:457-464 (Pubitemid 38296804)
21. Jeon SH, Lee MY, Kim SJ, Joe SG, Kim GB, Kim IS, Kim NS, Hong CU, Kim SZ, Kim JS, Kang HS (2007) Taurine increases cell proliferation and generates an increase in [Mg2?]i accompanied by ERK 1/2 activation in human osteoblast cells. FEBS Lett 581:5929-5934
22. Junyent F, Romero R, de Lemos L, Utrera J, Camins A, Pallàs M, Auladell C (2010) Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brain. J Neurosci Res 88:136-142
23. Karege F, Perroud N, Burkhardt S, Schwald M, Ballmann E, La Harpe R, Malafosse A (2007) Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims. Biol Psychiatry 61:240-245 (Pubitemid 46072784)
24. Kobayashi K, Ikeda Y, Sakai A, Yamasaki N, Haneda E, Miyakawa T, Suzuki H (2010) Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci USA 107:8434-8439
25. Kobayashi K, Ikeda Y, Suzuki H (2011) Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine. Mol Brain 4:12
26. Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83:271-276
27. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902
28. Lima L, Cubillos S (1998) Taurine might be acting as a trophic factor in the retina by modulating phosphorylation of cellular proteins. J Neurosci Res 53:377-384 (Pubitemid 28350401)
29. Lutter M, Krishnan V, Russo SJ, Jung S, McClung CA, Nestler EJ (2008) Orexin signaling mediates the antidepressant-like effect of calorie restriction. J Neurosci 28:3071-3075 (Pubitemid 351442272)
30. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, Zeng H, Caron MG, Tonegawa S (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100:8987-8992 (Pubitemid 36899210)
31. Miyazaki T, Matsuzaki Y, Ikegami T, Miyakawa S, Doy M, Tanaka N, Bouscarel B (2004) Optimal and effective oral dose of taurine to prolong exercise performance in rat. Amino Acids 27:291-298 (Pubitemid 40110070)
32. Murakami T, Furuse M (2010) The impact of taurine-and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: antidepressant versus anxiolytic-like effects. Amino Acids 39:427-434
33. Murakami T, Yamane H, Tomonaga S, Furuse M (2009) Forced swimming and imipramine modify plasma and brain amino acid concentrations in mice. Eur J Pharmacol 602:73-77
34. Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL (1975) Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol 32:108-113
35. Qi X, Lin W, Li J, Pan Y, Wang W (2006) The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 175:233-240 (Pubitemid 44750226)
36. Sergeeva OA, Chepkova AN, Doreulee N, Eriksson KS, Poelchen W, Mönnighoff I, Heller-Stilb B, Warskulat U, Häussinger D, Haas HL (2003) Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. J Physiol 550:911-919 (Pubitemid 37010073)
37. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261 (Pubitemid 35379212)
38. Silva AJ, Paylor R, Wehner JM, Tonegawa S (1992a) Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257:206-211
39. Silva AJ, Stevens CF, Tonegawa S, Wang Y (1992b) Deficient hippocampal long-term potentiation in alpha-calcium-calmodu-lin kinase II mutant mice. Science 257:201-206
40. Suárez LM, Solís JM (2006) Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons. Eur J Neurosci 24:405-418 (Pubitemid 44100333)
41. Takao K, Tanda K, Nakamura K, Kasahara J, Nakao K, Katsuki M, Nakanishi K, Yamasaki N, Toyama K, Adachi M, Umeda M, Araki T, Fukunaga K, Kondo H, Sakagami H, Miyakawa T (2010) Comprehensive behavioral analysis of calcium/calmodu-lin-dependent protein kinase IV knockout mice. PLoS ONE 5:e9460
42. Tamai I, Senmaru M, Terasaki T, Tsuji A (1995) Na(?)-and Cl(-)-dependent transport of taurine at the blood-brain barrier. Biochem Pharmacol 50:1783-1793
43. Tanabe M, Nitta A, Ono H (2010) Neuroprotection via strychnine-sensitive glycine receptors during post-ischemic recovery of excitatory synaptic transmission in the hippocampus. J Pharmacol Sci 113:378-386
44. Timbrell JA, Seabra V, Waterfield CJ (1995) The in vivo and in vitro protective properties of taurine. Gen Pharmacol 26:453-462
45. Tiraboschi E, Giambelli R, D'Urso G, Galietta A, Barbon A, de Bartolomeis A, Gennarelli M, Barlati S, Racagni G, Popoli M (2004) Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. NeuroReport 15:2393-2396 (Pubitemid 39488926)
46. Tomida S, Mamiya T, Sakamaki H, Miura M, Aosaki T, Masuda M, Niwa M, Kameyama T, Kobayashi J, Iwaki Y, Imai S, Ishikawa A, Abe K, Yoshimura T, Nabeshima T, Ebihara S (2009) Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nat Genet 41:688-695
47. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525
48. Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27:85-102 (Pubitemid 36131110)
49. Whirley BK, Einat H (2008) Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. Isr J Psychiatry Relat Sci 45:11-18
50. Whittle N, Sartori SB, Dierssen M, Lubec G, Singewald N (2007) Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 120:e1465-e1471 (Pubitemid 350223666)
51. Wong PT, Ong YP (2001) Acute antidepressant-like and antianxiety-like effects of tryptophan in mice. Pharmacology 62:151-156 (Pubitemid 32260855)
52. Wu JY, Prentice H (2010) Role of taurine in the central nervous system. J Biomed Sci 17(Suppl 1):S1
53. Xing G, Russell S, Hough C, O'Grady J, Zhang L, Yang S, Zhang LX, Post R (2002) Decreased prefrontal CaMKII alpha mRNA in bipolar illness. NeuroReport 13:501-505 (Pubitemid 34293199)
54. Yamasaki N, Maekawa M, Kobayashi K, Kajii Y, Maeda J, Soma M, Takao K, Tanda K, Ohira K, Toyama K, Kanzaki K, Fukunaga K, Sudo Y, Ichinose H, Ikeda M, Iwata N, Ozaki N, Suzuki H, Higuchi M, Suhara T, Yuasa S, Miyakawa T (2008) Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 1:6
55. Yatabe Y, Miyakawa S, Miyazaki T, Matsuzaki Y, Ochiai N (2003) Effects of taurine administration in rat skeletal muscles on exercise. J Orthop Sci 8:415-419 (Pubitemid 36702094)
56. Zheng WH, Quirion R (2004) Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J Neurochem 89:844-852 (Pubitemid 38684732)